Becton Dickinson and Co (NYSE:BDX)
| 226.37 BATS BZX Real-Time Price As of 10:23am ET |  +0.25 / +0.11%Today’s Change | 224.61 Today|||52-Week Range 277.29 | -7.67% Year-to-Date |
Latest BDX News | Press Releases
| 2 Top Dividend Kings to Buy for the Long Haul Sep 21 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 226.12 |
| Today’s open | 227.02 |
| Day’s range | 224.90 - 227.31 |
| Volume | 151,646 |
| Average volume (3 months) | 981,342 |
| Market cap | $66.7B |
Data as of 10:23am ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +151.71% |
| Earnings growth (this year) | -11.26% |
| Earnings growth (next 5 years) | +6.53% |
| Revenue growth (last year) | +18.29% |
| P/E ratio | 34.3 |
| Price/Sales | 3.55 |
| Price/Book | 2.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | +0.30 | +0.76% |
| DXCMDexcom Inc | -0.06 | -0.07% |
| BAXBaxter International... | +0.10 | +0.18% |
| ZBHZimmer Biomet Holdin... | +0.50 | +0.47% |
Data as of 10:23am ET, 09/30/2022
Financials
| Next reporting date | November 3, 2022 |
| EPS forecast (this quarter) | $2.75 |
| Annual revenue (last year) | $20.2B |
| Annual profit (last year) | $2.1B |
| Net profit margin | 10.33% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Franklin Lakes, New Jersey |
Forecasts
